These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 38436081)
1. Exploring future perspectives and pipeline progression in vaccine research and development. Vecchio R; Gentile L; Tafuri S; Costantino C; Odone A Ann Ig; 2024; 36(4):446-461. PubMed ID: 38436081 [TBL] [Abstract][Full Text] [Related]
2. Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution. Agampodi S; Mogeni OD; Chandler R; Pansuriya M; Kim JH; Excler JL Expert Rev Vaccines; 2024; 23(1):761-772. PubMed ID: 39167221 [TBL] [Abstract][Full Text] [Related]
3. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs. Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275 [TBL] [Abstract][Full Text] [Related]
4. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism. Amanpour S Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952 [TBL] [Abstract][Full Text] [Related]
5. Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines. Zhu C; Pang S; Liu J; Duan Q Drugs; 2024 Apr; 84(4):403-423. PubMed ID: 38652356 [TBL] [Abstract][Full Text] [Related]
6. The Coming of Age of Nucleic Acid Vaccines during COVID-19. Rando HM; Lordan R; Kolla L; Sell E; Lee AJ; Wellhausen N; Naik A; Kamil JP; ; Gitter A; Greene CS mSystems; 2023 Apr; 8(2):e0092822. PubMed ID: 36861992 [TBL] [Abstract][Full Text] [Related]
7. Project NextGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future. Hofmeyer KA; Ventura CL; Armstrong KL; Houchens CR; Patel S; Disbrow GL; Johnson RA; Clin Infect Dis; 2024 Jul; 79(1):115-121. PubMed ID: 38356144 [TBL] [Abstract][Full Text] [Related]
8. The quest for more effective vaccine markets - Opportunities, challenges, and what has changed with the SARS-CoV-2 pandemic. Cernuschi T; Malvolti S; Hall S; Debruyne L; Bak Pedersen H; Rees H; Cooke E Vaccine; 2024 Apr; 42 Suppl 1(Suppl 1):S64-S72. PubMed ID: 38103962 [TBL] [Abstract][Full Text] [Related]
9. Recombinant protein vaccines, a proven approach against coronavirus pandemics. Pollet J; Chen WH; Strych U Adv Drug Deliv Rev; 2021 Mar; 170():71-82. PubMed ID: 33421475 [TBL] [Abstract][Full Text] [Related]
10. Improving pandemic preparedness through better, faster influenza vaccines. Newland M; Durham D; Asher J; Treanor JJ; Seals J; Donis RO; Johnson RA Expert Rev Vaccines; 2021 Mar; 20(3):235-242. PubMed ID: 33576708 [No Abstract] [Full Text] [Related]
11. Meeting Summary: Global Vaccine and Immunization Research Forum, 2021. Ford A; Hwang A; Mo AX; Baqar S; Touchette N; Deal C; King D; Earle K; Giersing B; Dull P; Hall BF Vaccine; 2023 Mar; 41(11):1799-1807. PubMed ID: 36803897 [TBL] [Abstract][Full Text] [Related]
12. Factors, enablers and challenges for COVID-19 vaccine development. Excler JL; Saville M; Privor-Dumm L; Gilbert S; Hotez PJ; Thompson D; Abdool-Karim S; Kim JH BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37277195 [TBL] [Abstract][Full Text] [Related]
13. A COVID-19 vaccine-dare to dream. Phillis A Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510 [TBL] [Abstract][Full Text] [Related]
14. Pandemics: Historically Slow "Learning Curve" Leading to Biomedical Informatics and Vaccine Breakthroughs. Kulikowski CA Yearb Med Inform; 2021 Aug; 30(1):290-301. PubMed ID: 33882592 [TBL] [Abstract][Full Text] [Related]
15. Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa. Kana BD; Arbuthnot P; Botwe BK; Choonara YE; Hassan F; Louzir H; Matsoso P; Moore PL; Muhairwe A; Naidoo K; Ndomondo-Sigonda M; Madhi SA Lancet Infect Dis; 2023 Aug; 23(8):e288-e300. PubMed ID: 37290473 [TBL] [Abstract][Full Text] [Related]
16. Vaccinology in the post-COVID-19 era. Rappuoli R; De Gregorio E; Del Giudice G; Phogat S; Pecetta S; Pizza M; Hanon E Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431690 [TBL] [Abstract][Full Text] [Related]
17. Comparing research and development, launch, and scale up timelines of 18 vaccines: lessons learnt from COVID-19 and implications for other infectious diseases. Mao W; Zimmerman A; Urli Hodges E; Ortiz E; Dods G; Taylor A; Udayakumar K BMJ Glob Health; 2023 Sep; 8(9):. PubMed ID: 37696544 [TBL] [Abstract][Full Text] [Related]
18. Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review). Calina D; Docea AO; Petrakis D; Egorov AM; Ishmukhametov AA; Gabibov AG; Shtilman MI; Kostoff R; Carvalho F; Vinceti M; Spandidos DA; Tsatsakis A Int J Mol Med; 2020 Jul; 46(1):3-16. PubMed ID: 32377694 [TBL] [Abstract][Full Text] [Related]
19. The vaccine journey for COVID-19: a comprehensive systematic review of current clinical trials in humans. Checcucci E; Piramide F; Pecoraro A; Amparore D; Campi R; Fiori C; Elhage O; Kotecha P; Vyakarnam A; Serni S; Dasgupta P; Porpiglia F Panminerva Med; 2022 Mar; 64(1):72-79. PubMed ID: 32456404 [TBL] [Abstract][Full Text] [Related]
20. Vaccines for neglected and emerging diseases in Brazil by 2030: the "valley of death" and opportunities for RD&I in Vaccinology 4.0. Homma A; Freire MDS; Possas C Cad Saude Publica; 2020; 36Suppl 2(Suppl 2):e00128819. PubMed ID: 33111747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]